Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Financials
Key financial figures for Mirum Pharmaceuticals, Inc. Common Stock (Q2 2026).
- Revenue
- $176M
- Net Income
- -$67M
- EPS
- $-1.06
- Total Assets
- $1.0B
- Operating Cash Flow
- -$44M
Full income statement, balance sheet, and cash flow for Mirum Pharmaceuticals, Inc. Common Stock on SentiSense.